Growth differentiation factor 15 as a biomarker of frailty: evidence from recent studies
GDF15 represents a promising biomarker for frailty, reflecting physical decline and risk of future frailty. Future research should address sex-specific effects, standardize assay protocols and frailty assessments, and explore the clinical utility of GDF15 to detect people at increased risk of decline in intrinsic capacity and frailty in a life course perspective.
Authors
- Shuli Lian
- Yves Rolland
- Philipe de Souto Barreto
Institutions
- Université Toulouse III - Paul Sabatier (FR)
- Inserm (FR)
- Université Fédérale de Toulouse Midi-Pyrénées (FR)
- Centre Hospitalier Universitaire de Toulouse (FR)
- Cottage Health (US)
Publication Details
- Journal
- Current Opinion in Clinical Nutrition & Metabolic Care
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1097/mco.0000000000001213
- Primary Topic
- GDF15 and Related Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00